Business Description
Creative Life Science Co Ltd
ISIN : TW0007837007
Total Employee Number:
25Description
Creative Life Science Co Ltd is engaged in providing products of microbiology, and it has prepared media products and diagnostic reagents. The main products of CMP (Creative Media Plate) are solid and liquid media, which can be used for clinical microbiology, basic microbial research, environmental monitoring, biosafety testing, and quality control. Its product line is Transport Medium, Prepared Tube Media, Prepared Plated Media, VTM & I-VTM, Bacterial strain preservation system, and CMP SteriPack triple wrapped media.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.85 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.49 | |||||
Debt-to-EBITDA | 1.44 | |||||
Interest Coverage | 21.13 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.8 | |||||
Beneish M-Score | -2.54 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.9 | |||||
3-Year EBITDA Growth Rate | -14.3 | |||||
3-Year EPS without NRI Growth Rate | -14.8 | |||||
3-Year FCF Growth Rate | -6.3 | |||||
3-Year Book Growth Rate | 25 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 1.31 | |||||
9-Day RSI | 6.23 | |||||
14-Day RSI | 11.78 | |||||
3-1 Month Momentum % | -16.36 | |||||
6-1 Month Momentum % | -18.22 | |||||
12-1 Month Momentum % | -16.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.55 | |||||
Quick Ratio | 1.27 | |||||
Cash Ratio | 0.71 | |||||
Days Inventory | 63.1 | |||||
Days Sales Outstanding | 58.4 | |||||
Days Payable | 34.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.85 | |||||
Dividend Payout Ratio | 0.4 | |||||
Forward Dividend Yield % | 3.25 | |||||
5-Year Yield-on-Cost % | 2.85 | |||||
Shareholder Yield % | 7 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 40.93 | |||||
Operating Margin % | 12.83 | |||||
Net Margin % | 10.78 | |||||
EBITDA Margin % | 22.24 | |||||
FCF Margin % | 7.46 | |||||
OCF Margin % | 22.46 | |||||
ROE % | 17.92 | |||||
ROA % | 8.77 | |||||
ROIC % | 14.07 | |||||
3-Year ROIIC % | -0.03 | |||||
ROC (Joel Greenblatt) % | 27.25 | |||||
ROCE % | 14.74 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 13.34 | |||||
PE Ratio without NRI | 13.34 | |||||
Price-to-Owner-Earnings | 12.01 | |||||
PS Ratio | 1.44 | |||||
PB Ratio | 2.13 | |||||
Price-to-Tangible-Book | 2.45 | |||||
Price-to-Free-Cash-Flow | 19.47 | |||||
Price-to-Operating-Cash-Flow | 6.43 | |||||
EV-to-EBIT | 11.34 | |||||
EV-to-EBITDA | 6.54 | |||||
EV-to-Revenue | 1.45 | |||||
EV-to-FCF | 20.28 | |||||
Price-to-Graham-Number | 1.2 | |||||
Earnings Yield (Greenblatt) % | 8.81 | |||||
FCF Yield % | 5.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Creative Life Science Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,098.539 | ||
| EPS (TTM) (NT$) | 5.18 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 25.47 | ||
| 14-Day RSI | 11.78 | ||
| 14-Day ATR (NT$) | 2.442984 | ||
| 20-Day SMA (NT$) | 83.495 | ||
| 12-1 Month Momentum % | -16.36 | ||
| 52-Week Range (NT$) | 68.9 - 121 | ||
| Shares Outstanding (Mil) | 22.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Creative Life Science Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Creative Life Science Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 2.336772 Cash Dividend | 2026-07-31 | In 10 days | ||
| TWD 2.050000 Cash Dividend | 2025-08-27 | 113.50 (+0.00%) |
Show
Entries
Creative Life Science Co Ltd Frequently Asked Questions
What is Creative Life Science Co Ltd(ROCO:7837)'s stock price today?
The current price of ROCO:7837 is NT$69.10. The 52 week high of ROCO:7837 is NT$121.00 and 52 week low is NT$68.90.
When is next earnings date of Creative Life Science Co Ltd(ROCO:7837)?
The next earnings date of Creative Life Science Co Ltd(ROCO:7837) is .
Does Creative Life Science Co Ltd(ROCO:7837) pay dividends? If so, how much?
The Dividend Yield %  of Creative Life Science Co Ltd(ROCO:7837) is 2.85% (As of Today), Highest Dividend Payout Ratio of Creative Life Science Co Ltd(ROCO:7837) was 0.4. The lowest was 0.39. And the median was 0.39. The  Forward Dividend Yield % of Creative Life Science Co Ltd(ROCO:7837) is 3.25%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Creative Life Science Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers